We further analyzed the expression of HLA-E, a ligand of NKG2A, in tumors and found that HLA-E was expressed on both tumor cells and immune cells in the tumors of NSCLC patients (Supplementary Figure 2). The gene discussed is HLA-E; the disease is non-small cell lung carcinoma.